Free Trial

Prime Medicine (PRME) Insider Trading & Ownership

Prime Medicine logo
$1.80 +0.18 (+11.11%)
Closing price 04:00 PM Eastern
Extended Trading
$1.80 -0.01 (-0.28%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Prime Medicine (NYSE:PRME) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
22.93%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$64.89K
Number Of
Insiders Selling
(Last 12 Months)
0
Get PRME Insider Trade Alerts

Want to know when executives and insiders are buying or selling Prime Medicine stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

PRME Insider Buying and Selling by Quarter

Prime Medicine Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/16/2025David R LiuMajor ShareholderBuy21,000$1.49$31,290.00  
6/11/2025David R LiuMajor ShareholderBuy21,000$1.60$33,600.00  
(Data available from 1/1/2013 forward)

PRME Insider Trading Activity - Frequently Asked Questions

The list of insiders at Prime Medicine includes 2019 Gp L.L.C. Gv, David R Liu, and Robert Nelsen. Learn more on insiders at PRME.

22.93% of Prime Medicine stock is owned by insiders. Learn more on PRME's insider holdings.

The following insiders have purchased PRME shares in the last 24 months: David R Liu ($64,890.00), and Robert Nelsen ($20,000,000.00).

Insiders have purchased a total of 3,242,000 PRME shares in the last 24 months for a total of $20,064,890.00 bought.

The following insider sold PRME shares in the last 24 months: 2019 Gp L.L.C. Gv ($563,319.30).

Insiders have sold a total of 37,405 Prime Medicine shares in the last 24 months for a total of $563,319.30 sold.

Prime Medicine Key Executives

  • Dr. Keith Michael Gottesdiener M.D. (Age 70)
    Ph.D., President, CEO, Secretary & Director
    Compensation: $1.06M
  • Dr. Ann L. Lee Ph.D. (Age 62)
    Chief Technical Officer
    Compensation: $684.78k
  • Dr. Jeremy S. Duffield M.D. (Age 56)
    Ph.D., Chief Scientific Officer
    Compensation: $680.65k
  • Dr. Andrew Anzalone M.D. (Age 37)
    Ph.D., Co-Founder & Head of Prime Editing Platform
  • Dr. David R. Liu Ph.D.
    Co-Founder & Chair of Scientific Advisory Board
  • Dr. Allan Reine M.D. (Age 49)
    Chief Financial Officer
  • Dr. Meredith Goldwasser (Age 53)
    Senior VP and Head of Strategy & Corporate Operations
  • Ms. Carman Alenson CPA (Age 58)
    M.B.A., Senior VP of Finance & Chief Accounting Officer
  • Dr. Karen Brown J.D.
    Ph.D., Senior Vice President of Intellectual Property & Legal Affairs
  • Ms. Niamh Alix
    Chief Human Resources Officer


This page (NYSE:PRME) was last updated on 6/18/2025 by MarketBeat.com Staff
From Our Partners